Global /India /Healthcare /Drug Manufacturers - Specialty & Generic /524400

Ishita Drugs and Industries Ltd.

524400 (ISHITADR)

• BSE: 524400 • Delayed

80.62INR -1.7%

0.8432 USD

As of 9 June 2026, Ishita Drugs and Industries Ltd. has a market cap of $2.53M USD, ranking #46634 globally and #4397 in India. It ranks #4123 in the Healthcare sector, and #306 in the Drug Manufacturers - Specialty & Generic industry.

Global Rank

46634

Country Rank

4397

Sector Rank

4123

Industry Rank

306

Key Stats

Market Cap

$2.53MUSD

241.08M INR

Enterprise Value

$1.61MUSD

154.11M INR

Revenue (TTM)

$1.7MUSD

161.68M INR

EBITDA (TTM)

$100.67KUSD

9.63M INR

Net Income (TTM)

$93.22KUSD

8.89M INR

EBITDA Margin

Profit Margin

5.5%

PE Ratio

27.1

PS Ratio

1.5

PB Ratio

2.1

EV/EBITDA

16.0

Company Profile

Country (HQ)

India

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Jagdishprasad Agrawal open_in_new

Employees

Founded

1992

Website

ishitadrugs.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-1.7%	6.1%	19%	20%	12%	2.5%	-1.8%	59%	152%

News

Markets

Exchange	Ticker	Price	Quotes
Bombay Stock Exchange (BSE / BOM) MIC: XBOM PRIMARY	524400 (ISHITADR) Ishita Drugs And Industries Ltd ISIN: INE806D01016 Shares Out.: Shares Outstanding: 2.99M¹ TV: TradingView: BSE: ISHITADR SA: Stock Analysis: BOM: 524400 YF: Yahoo Finance: 524400.BO GF: Google Finance: BOM: 524400 BA: Barron's: 524400 MS: Morningstar: XBOM: 524400	80.62 INR	TV: TradingView: BSE: ISHITADR SA: Stock Analysis: BOM: 524400 YF: Yahoo Finance: 524400.BO GF: Google Finance: BOM: 524400 BA: Barron's: 524400 MS: Morningstar: XBOM: 524400

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Ishita Drugs and Industries Ltd.

Ishita Drugs and Industries Limited manufactures and sells active pharma ingredients (APIs), fine chemicals, drug intermediates, and excipients in India and internationally. The company offers APIs, such as sulfa drugs/sulfonamides, vitamins, fluoro quinolones, antibiotics, anthelmintics, iodides and citrates, food additives/excipients, and others. It also provides contract manufacturing services for various drug intermediates, fine chemicals, or specialty chemicals. Ishita Drugs and Industries Limited was incorporated in 1992 and is based in Ahmedabad, India.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (India)

Name	Market Cap (USD) diff.	PE	Country
Cipla Ltd. NSE: CIPLA	$11.16B 1.06T INR 441K%	23.4	India
Lupin Ltd. NSE: LUPIN	$11.04B 1.05T INR 437K%	22.7	India
Aurobindo Pharma Ltd. NSE: AUROPHARMA	$8.46B 807.02B INR 335K%	23.1	India
Cohance Lifesciences Ltd. NSE: SUVENPHAR	$1.88B 178.87B INR 74K%	199.0	India
Granules India Ltd. NSE: GRANULES	$1.83B 174.85B INR 72K%	32.1	India
Viyash Scientific Ltd. NSE: SEQUENT	$948.71M 90.48B INR 37K%	92.7	India

Industry: Drug Manufacturers - Specialty & Generic (Global)

Name	Market Cap (USD) diff.	PE	Country
Teva Pharmaceutical Industries Ltd. TLV: TEVA	$37.17B 108.92B ILS 1M%	24.2	Israel
Revolution Medicines, Inc. NASDAQ: RVMD	$29.56B 1M%	-	United States
Zhejiang NHU Company Ltd. SHE: 002001	$15.86B 107.34B CNY 627K%	16.0	China
Haisco Pharmaceutical Group Co., Ltd. SHE: 002653	$9.1B 61.6B CNY 360K%	80.6	China
ABIVAX Société Anonyme EPA: ABVX	$8.72B 7.57B EUR 345K%	-	France
Dong-E-E-Jiao Co., Ltd. SHE: 000423	$5.22B 35.33B CNY 206K%	20.0	China

chevron_leftBack